Table I. Demographic and clinical characteristics.
| Characteristics | Multi-omics-morphology | Morphology-Clinical analysis |
|---|---|---|
| Patient No. | 73 | 1,057 |
| PAM50 Subtype Patient No.a | ||
| basal-like | 18 | 135 |
| luminal A | 22 | 403 |
| luminal B | 23 | 186 |
| HER2-enriched | 10 | 62 |
| Biomarker Status Patient No.a (Positive/Negative) | ||
| ER Status | 49/24 | 778/232 |
| PR_Status | 41/32 | 674/333 |
| HER2 Status | 16/56 | 158/546 |
| Age (years) | ||
| Range | 30∼88 | 26∼90 |
| Median | 58 | 58 |
| AJCC Stagea | ||
| Stage I | 8 | 182 |
| Stage II | 48 | 610 |
| Stage III | 16 | 245 |
| Stage IV | 1 | 20 |
| Follow-up (days) | ||
| Range | 5∼3316 | 1∼8605 |
| Median | 1148 | 865 |
| Vital_Status | ||
| Living | 66 | 917 |
| Deceased | 7 | 140 |
aSome information is missing for certain patients.